Tenofovir disoproxil fumarate significantly decreases serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B carriers.

A A ShaheenM AlMattooqS YazdanfarK W BurakM G SwainS E ConglyM A BormanS S LeeR P MyersCarla S Coffin

Published in: Alimentary pharmacology & therapeutics (2017)

A greater decline in TC, LDL-C and HDL was observed in CHB carriers receiving TDF compared with ETV. These data may influence anti-viral choice in CHB carriers at risk for CVD.

Keyphrases

hepatitis b virus
big data
stem cells
machine learning
bone marrow
deep learning
liver fibrosis